CONNECTING Healthcare EXPERTISE

THE CLINICIAN EXCHANGE is a virtual exchange designed to pair specific clinical skillsets with specific industry initiatives.

EXCHANGE YOUR EXPERTISE

Learn how you can unlock the power of your expertise and experience to impact the healthcare industry in ways never before imagined

REGISTER NOWLEARN MORE

EXTEND, EXCEL…EXPLORE THE EXCHANGE

Learn how you can cost-effectively multiply your sales, education and R&D resources in an instant

REGISTER NOWLEARN MORE

COMMUNITY PORTAL

IN THE NEWS

CLINICIAN NEWS

Provided by: Medscape

Microbiome Profiling: Big Business, but What About the Data?

Published: Mon, 26 Jun 2017 09:14:54 EDT
Personalized microbiome testing kits are more and more common. Does the science back up their usefulness?
Medscape Gastroenterology

CDC Contraception Guidelines: The Latest Updates

Published: Mon, 26 Jun 2017 09:11:40 EDT
Here are the hot-off-the-press revisions to CDC contraception guidelines and recommendations.
CDC Expert Commentary

Robust Association Between Migraine and Sleep Apnea

Published: Mon, 26 Jun 2017 08:55:50 EDT
Results from the CaMEO study suggest that if migraine and sleep apnea are linked, then treating the apnea might reduce headache frequency.
Medscape Medical News
Displaying results 7-9 (of 20)
 1 - 2 - 3 - 4 - 5 - 6 - 7 

HEALTHCARE SUPPLIER NEWS

Novartis-backed GenSight gets cash for gene therapy launch

Published: Fri, 23 Jun 2017 09:12:53 +0000
GenSight Biologics has raised €22.5 million ($25.2 million) to prepare to bring gene therapy GS010 to market in the U.S. and Europe. The financing gives the Novartis-backed biotech enough cash to deliver data from two phase 3 trials next year and gear up for anticipated approvals on both sides of the Atlantic.

EuroBiotech: More Articles of Note

Published: Thu, 22 Jun 2017 13:14:34 +0000
In our EuroBiotech roundup this week, Galapagos delays cystic fibrosis program, Zealand heads to phase 3 and Pluristem loses out on $30 million. 

Biotech bounces as the bones of Trump's plans on pricing emerge

Published: Thu, 22 Jun 2017 12:59:20 +0000
Biotech stocks are enjoying their most buoyant patch in months, with three straight days of solid gains on reports that President Donald Trump's threatened crackdown on pricing may not be as tough as feared.
Displaying results 7-9 (of 25)
 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 

HAVE A QUESTION?

Clinician Owned and Veteran Owned

copyright 2017 THE CLINICIAN EXCHANGE. Privacy Policy
Top